Literature DB >> 31117372

Cell-Membrane-Cloaked Oil Nanosponges Enable Dual-Modal Detoxification.

Yijie Chen1, Yue Zhang1, Jia Zhuang1, Joo Hee Lee1, Licheng Wang1, Ronnie H Fang1, Weiwei Gao1, Liangfang Zhang1.   

Abstract

The lack of pharmaceutical antidotes for deadly toxicants has motivated tremendous research interests in seeking synthetic nanoscavengers to absorb and neutralize harmful biological or chemical agents. Herein, we report a cell-membrane-cloaked oil nanosponge formulation capable of dual-modal detoxification. The biomimetic oil nanosponge consists of an olive oil nanodroplet wrapped by a red blood cell membrane. In such a construct, the oil core can nonspecifically soak up toxicants through physical partition and the cell membrane shell can specifically absorb and neutralize toxicants through biological binding. The dual-modal detoxification capability of the oil nanosponges was validated using three distinct organophosphates (OPs), including paraoxon, diisopropyl fluorophosphate, and dichlorvos. By inhibiting acetylcholinesterase, OPs cause the accumulation of acetylcholine, which leads to neuromuscular disorders and even death. In mouse models of OP poisoning, the oil nanosponges reduced clinical signs of OP intoxication, lowered OP concentration in tissues, and greatly enhanced mouse survival in both the therapeutic regimen and the prophylactic regimen. Overall, oil nanosponges combine the merits of both cell membrane and oil nanodroplets for safe and effective detoxification, which also serve as a prototype of multimodal detoxification platforms.

Entities:  

Keywords:  antidote; biodetoxification; biomimetic nanoparticle; cell membrane; organophosphate compound

Year:  2019        PMID: 31117372     DOI: 10.1021/acsnano.9b02773

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  8 in total

Review 1.  Latest Advances in Biomimetic Cell Membrane-Coated and Membrane-Derived Nanovectors for Biomedical Applications.

Authors:  Riccardo Rampado; Paolo Caliceti; Marco Agostini
Journal:  Nanomaterials (Basel)       Date:  2022-05-02       Impact factor: 5.719

Review 2.  Recent Progress in Red Blood Cells-Derived Particles as Novel Bioinspired Drug Delivery Systems: Challenges and Strategies for Clinical Translation.

Authors:  Antony Vincy; Sarmistha Mazumder; Indranil Banerjee; Kuo Chu Hwang; Raviraj Vankayala
Journal:  Front Chem       Date:  2022-04-27       Impact factor: 5.545

3.  Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived.

Authors:  Jun Dai; Zhaojun Chen; Shixuan Wang; Fan Xia; Xiaoding Lou
Journal:  Mater Today Bio       Date:  2022-05-05

Review 4.  Nanotechnology for virus treatment.

Authors:  Jiarong Zhou; Nishta Krishnan; Yao Jiang; Ronnie H Fang; Liangfang Zhang
Journal:  Nano Today       Date:  2020-12-01       Impact factor: 20.722

5.  Preparation, Biosafety, and Cytotoxicity Studies of a Newly Tumor-Microenvironment-Responsive Biodegradable Mesoporous Silica Nanosystem Based on Multimodal and Synergistic Treatment.

Authors:  Zelai He; Huijun Zhang; Hongwei Li; Yanyan Wang; Jing Qian; Xixi Cai; Li Sun; Jingwen Huang
Journal:  Oxid Med Cell Longev       Date:  2020-11-05       Impact factor: 6.543

6.  Fibroblast membrane-camouflaged nanoparticles for inflammation treatment in the early stage.

Authors:  Lizhong Sun; Libang He; Wei Wu; Li Luo; Mingyue Han; Yifang Liu; Shijie Shi; Kaijing Zhong; Jiaojiao Yang; Jiyao Li
Journal:  Int J Oral Sci       Date:  2021-11-16       Impact factor: 6.344

Review 7.  Engineered Cell Membrane-Derived Nanocarriers: The Enhanced Delivery System for Therapeutic Applications.

Authors:  Biao Yu; Xu Xue; Zhifeng Yin; Liehu Cao; Mengmeng Li; Jianping Huang
Journal:  Front Cell Dev Biol       Date:  2022-02-28

8.  Brain-Targeted Biomimetic Nanodecoys with Neuroprotective Effects for Precise Therapy of Parkinson's Disease.

Authors:  Yao Liu; Jingshan Luo; Yujing Liu; Wen Liu; Guangtao Yu; Yuting Huang; Yu Yang; Xiaojia Chen; Tongkai Chen
Journal:  ACS Cent Sci       Date:  2022-09-13       Impact factor: 18.728

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.